Cory R. Trankle - Concepedia

Author

Cory R. Trankle

Also Known As

C R Trankle, C Trankle, C. Trankle, C.R Trankle, C.R. Trankle, Cory R TRANKLE, Cory R Trankle, Cory R. TRANKLE, Cory R. Trankle, Cory Ross Trankle

174

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Virginia Commonwealth University Sapienza University of Rome University of Illinois Chicago Clinica Mediterranea University of Illinois Urbana-Champaign

About

Cory R. Trankle is an author at Virginia Commonwealth University specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	879
2	Health Sciences	6	6	251
3	Education	3	3	53
4	Applied Physiology	2	2	94
5	Biomedical Engineering	1	1	14

Cory R. Trankle

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction Antonio Abbate, Cory R. Trankle, Leo F. Buckley, Journal of the American Heart Association	2020	281
Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi Austin Robinson, Cory R. Trankle, Grayson Eubanks, JAMA Cardiology	2020	243
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure Benjamín W. Van Tassell, Justin M. Canada, Salvatore Carbone, Circulation Heart Failure	2017	232
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction Benjamín W. Van Tassell, Cory R. Trankle, Justin M. Canada, Circulation Heart Failure	2018	202
Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies) Antonio Abbate, Michael C. Kontos, Nayef Abouzaki, The American Journal of Cardiology InflammationThrombosisCardiovascular DiseaseVcu-art2 Pilot StudiesComparative Safety	2014	156
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure George F. Wohlford, Benjamín Van Tassell, Hayley Billingsley, Journal of Cardiovascular Pharmacology Heart FailureCardiovascular PharmacologyPharmacotherapyCardiovascular ToxicityAcute Myocardial Infarction	2020	138
Interleukin-1 Blockade in Acute Decompensated Heart Failure Benjamín W. Van Tassell, Nayef Abouzaki, Claudia Oddi Erdle, Journal of Cardiovascular Pharmacology	2016	130
Acute Myocarditis Associated With Desmosomal Gene Variants Enrico Ammirati, Francesca Raimondi, Nicolas Piriou, JACC Heart Failure CardiomyopathyPathogenesisPathologyAcute Myocarditis AssociatedMedicine	2022	118
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials Antonio Abbate, George F. Wohlford, Marco Giuseppe Del Buono, European Heart Journal - Cardiovascular Pharmacotherapy	2021	100
Low NT-proBNP Levels in Overweight and Obese Patients Do Not Rule Out a Diagnosis of Heart Failure with Preserved Ejection Fraction Leo F. Buckley, Justin M. Canada, Marco Giuseppe Del Buono, ESC Heart Failure	2018	78

Page 1